Guideline for Good Clinical Practice (GCP)

Published By : Jordan Food and Drug Administration | Consultation Type : Other |

Health

Closed

Published Consultation

3/18/2026
Comment End Date

4/18/2026
Consultation Definition

4/18/2026
Consultation Results

4/30/2026

Subject of consultation
Activities
Full legal text

Objectives

These guidelines aim to ensure that clinical trials are conducted in accordance with Good Clinical Practice (GCP) and that the rights, safety, and well-being of clinical studies participants are protected. They also aim to ensure that the conduct of such trials is consistent with the principles originating from the Declaration of Helsinki, while guaranteeing the reliability of clinical studies results.

Summary

Good Clinical Practice (GCP) is an international, ethical, scientific and quality standard for the conduct of clinical studies that involve human participants. Clinical studies conducted in accordance with this standard will help to ensure that the rights, safety and well-being of clinical studies participants are protected; that the conduct is consistent with the principles that have their origin in the Declaration of Helsinki; and that the clinical study results are reliable. The term “trial conduct” in this document includes processes from planning to reporting, including planning, initiating, performing, recording, oversight, evaluation, analysis and reporting activities as appropriate. JFDA adheres to the standards regulating the foundations of Good Clinical Practice (GCP) in accordance with the rules of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH (E6)-GCP) and its updates as a scientific reference and in accordance with the local laws and instructions regulating clinical studies conducted in Jordan issued by JFDA.